Hearing loss in mammals is an irreversible process caused by degeneration of the hair cells of the inner ear. Current therapies for hearing loss include hearing aids and cochlear implants that provide substantial benefits to most patients, but also have several shortcomings. There is great interest in the development of regenerative therapies to treat deafness in the future. Cell-based therapies, based either on adult, multipotent stem, or other types of pluripotent cells, offer promise for generating differentiated cell types to replace lost or damaged hair cells of the inner ear. In this review, we focus on the methods proposed and avenues for research that seem the most promising for stem cell-based auditory sensory cell regeneration, from work collected over the past 15 years.
Inner Ear Hair Cell Regeneration
Hearing loss affects 11% of the US population aged 50-59 years and 25% of the population at ages 60-69 years [1] . Globally, more than 360 million people have disabling hearing loss (according to WHO). Hearing loss is most commonly caused by aging, ototoxic medications, noise exposure, diseases of the inner ear, hereditary disorders, and congenital conditions. Most cases of acquired hearing loss are due to degeneration and subsequent loss of cochlear hair cells (HCs) located in the organ of Corti (OC; Figure 1 ).
The OC is the auditory sensory epithelium that consists of one row of inner and three rows of outer HCs (OHC) that rest upon a cohort of different types of supporting cells (Figure 1 ). The inner HCs (IHC) act as mechanosensors by converting sound-induced basilar membrane vibration into an electrical signal. Afferent spiral ganglion neurons receive input from the IHC and transmit this information to the cochlear nucleus in the brainstem followed by relay ultimately to the auditory cortex. The OHC are responsible for amplification of the incoming signal via somatic electromotility. The mammalian cochlea is tonotopically organized with highfrequency reception in the base progressing to low frequencies in the apex. The cochlea is encapsulated in particularly dense bone located within the temporal bone, one of the osseous structures that make up the base of skull.
Studies in the late 1980s revealed that the avian auditory sensory epithelium is capable of regeneration after lesioning, and subsequent similar findings were observed in rodents (albeit in more limited contexts). These results have piqued the interest of many auditory scientists in understanding inner ear HC and supporting cell development and regeneration, so that targeted biological therapies for hearing loss may be developed. Multiple approaches to HC regeneration have been proposed including gene transfer, pharmacotherapies, and stem cell-based approaches. In recent years there have been many studies investigating two stem cell-based approaches for hearing loss (Figure 2 ). The first approach is based on the regeneration of cochlear HCs from multipotent inner ear progenitor cells that reside in the OC. The second approach is based upon in vitro differentiation of pluripotent stem cells (PSCs) to an
Highlights
Mouse and human pluripotent stem cells can be differentiated into an inner ear supporting cell and functional hair cell fate in vitro as well as into inner ear organoids.
Progenitor cells capable of differentiation into inner ear hair cells have been identified in the neonatal and early adult cochlea.
Transplantation of pluripotent stem cell-derived progenitors into the chick auditory sensory epithelium as well as the adult rodent auditory nerve leads to survival and terminal differentiation of grafted cells.
Transplantation of pluripotent stem cell-derived progenitors into the normal and lesioned rodent cochlea leads to survival, but not integration or terminal differentiation, of grafted cells.
